Preparation of pH/Light dual-responsive biocompatible polymer micelles: Application to curcumin delivery
Xinjing Wang,Yi Wu,Hongzhou Shang,Xiaoran Sun,Kexin An,Qian Zhang,Ning Qiao
DOI: https://doi.org/10.1016/j.jddst.2023.104652
IF: 5
2023-06-25
Journal of Drug Delivery Science and Technology
Abstract:Polymer micelles play an important role in the research of drug delivery system because of their nano-size, unique "core-shell" structure and surface modifiability. A pH/photosensitive drug carrier, PEG-PDMAEMA-PNBAE, was synthesized by atom transfer radical polymerization (ATRP) using hydrophilic poly (N, N dimethylaminoethyl methacrylate) (PDMAEMA) as the pH-responsive chain segment and hydrophobic poly (o-nitrobenzyl acrylate) (PNBAE) as the light-responsive chain segment. The molecular and structural characteristics of the polymer were spectroscopically characterized with Fourier transform infrared spectrometer (FT-IR), Nuclear magnetic resonance hydrogen spectrum ( 1 H NMR) and Gel permeation chromatography column (GPC). The morphology and size of micelles were observed by Scanning electron microscope (SEM) and Transmission electron microscope (TEM). The stability of micelles was detected by Laser particle size analyzer (DLS). The Critical micelle concentration (CMC) of the polymer was analyzed by Fluorescence spectrophotometer (Flu), and the photosensitivity of the micelles was determined by Ultraviolet–visible spectrophotometer (UV). The results showed that the synthesized polymers could self-assemble into homogeneous and stable spherical micelles and their particle size was about 100 nm with effective light sensitivity. Curcumin (Cur) was used as a model drug to investigate the adsorption and release abilities of the micelles. The adsorption performance test of the polymeric micelles showed an encapsulation rate of 77.82% and a drug loading capacity of 13.46%. In vitro drug release results showed cumulative drug release rates of 31.79% and 46.55% at pH 5.5 and pH 5.5+UV, indicating the dual pH and light responsiveness of the synthesized carrier. The in vitro hemolysis and cytotoxicity test demonstrated that the carrier has good biosafety. Graphical abstract Download : Download high-res image (202KB) Download : Download full-size image Major challenges faced in anticancer therapy include inefficient therapeutic transportation to tumor cells and chemotherapy-associated toxicity with severe adverse drug reactions. In this context, recent advancements in supramolecular polymer (SMP) chemi-structures offer structurally infused anticancer elements into nanocarrier systems in addition to encapsulated chemotherapeutic agents for synergistically-enhanced anti-cancer therapy. Designated supramolecular frameworks are feasibly obtained via rapid synthetic processes and are bioengineered to self-assemble into various delivery forms like nanoparticles, nanomicelles, etc. to achieve desirable therapeutic properties such as encapsulation of hydrophobic (Doxorubicin) as well as hydrophilic drugs (Camptothecin, Magnolol, etc.), enhanced entrapment efficiency (>80%) and a sustained therapeutic profile (72 h). Cell-internalization is improved by incorporation of sensitive proteins (monoclonal antibodies) and genetic material (siRNA, siETS1, shRNA, etc.), Moreover, multistimuli-sensitive linkages like and functional moieties present in the SMP-composition automatically modulate the chemical structure of the carriers in tumor-specific parameters as acidic pH, elevated temperature, increased oxidative radicals, etc. as well as exogenous triggers like light, ultrasound, magnetic field and electric potential initiate the structural auto-modulation of carrier system to reduce therapy-associated toxicity and offer protection to non-cancerous cells. These biocompatible constructs emerge as the focus of theranostics with potential applications in biosensing for qualitative analysis, quantitative evaluation and effective anti-cancer therapy. Thermoresponsive drug delivery systems have been used previously to deliver chemotherapeutic agents to tumors in a hyperthermic microenvironment. The objective of the present study was to fabricate and characterize Cisplatin-loaded thermoresponsive liposomes () for enhanced anticancer efficacy. were prepared by a thin-film hydration method with varied ratios of dipalmitoyl phosphatidylcholine and hydrogenated soy phosphatidylcholine, and fixed amounts of distearyl phosphoethanolamine polyethylene glycol 2000 and Cisplatin. The prepared had a particle size of up to 201.8 nm, surface a charge of −6.31 mV, high entrapment efficiency of Cisplatin, and thermoresponsive release behavior. The were tested in vitro for cytotoxicity against A549 cells (lung carcinoma), SKOV-3 cells (ovarian cancer) and MDA-MB-231 cells (br -Abstract Truncated-
pharmacology & pharmacy